Axon Enterprise reported robust Q3 2024 results, with revenue soaring 31.7% year-over-year to $544.3 million. The TASER segment saw a 36.4% increase, driven by higher TASER 10 device and cartridge volumes. Software and Sensors segment revenue grew 28.7%, fueled by increased users and adoption of premium features.Net income reached $67.0 million, including a $44.0 million unrealized gain on marketable securities. Gross margin decreased slightly to 60.8% from 62.1% in Q3 2023, primarily due to higher stock-based compensation expenses. Operating expenses rose significantly, reflecting increased headcount and stock-based compensation costs.Axon's future contracted revenue stood at $7.7 billion as of September 30, 2024. The company maintains a strong liquidity position with $1.01 billion in cash and investments. Management expects continued growth, driven by expanding user base and increasing adoption of premium services across its integrated product ecosystem.

Axon Enterprise reported robust Q3 2024 results, with revenue soaring 31.7% year-over-year to $544.3 million. The TASER segment saw a 36.4% increase, driven by higher TASER 10 device and cartridge volumes. Software and Sensors segment revenue grew 28.7%, fueled by increased users and adoption of premium features.Net income reached $67.0 million, including a $44.0 million unrealized gain on marketable securities. Gross margin decreased slightly to 60.8% from 62.1% in Q3 2023, primarily due to higher stock-based compensation expenses. Operating expenses rose significantly, reflecting increased headcount and stock-based compensation costs.Axon's future contracted revenue stood at $7.7 billion as of September 30, 2024. The company maintains a strong liquidity position with $1.01 billion in cash and investments. Management expects continued growth, driven by expanding user base and increasing adoption of premium services across its integrated product ecosystem.